"Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients." Neurology - Neuroimmunology Neuroinflammation
7.6
(2020):
e882.
Web. 03 Dec. 2021.
Advertisement